← Leaderboards
Nathan G. Dolloff
Medical University Of South Carolina
$2,979,921
Attributed
$2,979,921
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $837.6K · FY2016–24$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,979,921 · 3
By mechanism
R01$2,408,503 · 1
R41$362,118 · 1
P20$209,300 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Robert K Stuart$511,005
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroPre-ClinicalTreatment ProtocolsIn VivoInnovationMouse ModelProgramsBindingKnock-DownGenetically Engineered MouseInsightLeadExpectationEffective TherapyExperimental StudyCoupledDiagnosisCell ModelCancer ModelDrug TargetingExhibitsCancer TherapyClinicAffinity
Grant awards (7)
Inhibitors of Oxidative Protein Folding For The Treatment of Cancer$475,823
R01 · FY2024 · CA · contact PI
Inhibitors of Oxidative Protein Folding For The Treatment of Cancer$490,849
R01 · FY2023 · CA · contact PI
Inhibitors of Oxidative Protein Folding For The Treatment of Cancer$490,849
R01 · FY2022 · CA · contact PI
Inhibitors of Oxidative Protein Folding For The Treatment of Cancer$475,491
R01 · FY2021 · CA · contact PI
Bispecific T cell engagers for the treatment of pancreatic ductal adenocarcinoma$362,118
R41 · FY2021 · CA · contact PI
Inhibitors of Oxidative Protein Folding For The Treatment of Cancer$475,491
R01 · FY2020 · CA · contact PI
Project 3: Targeting redox regulation in proteasome inhibitor resistant multiple myeloma$209,300
P20 · FY2016 · GM · contact PI